S'abonner

Expression of p53 in the evolution of squamous cell carcinoma: Correlation with the histology of the lesion - 19/08/11

Doi : 10.1016/j.jaad.2007.04.025 
Aviv Barzilai, MD, MSc a, b, c, , Anna Lyakhovitsky, MD a, b, Henri Trau, MD a, b, Mina Fogel, PhD c, d, Monika Huszar, MD c, e
a Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Israel 
b Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel 
c Department of Pathology, Kaplan Medical Center, Rehovot, Israel 
d Faculty of Health Sciences, HaNegev University, Beer Sheba, Israel 
e Faculty of Medicine, The Hebrew University, Jerusalem, Israel 

Reprint requests: Aviv Barzilai, MD, MSc, Department of Dermatology, The Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel.

Abstract

Background

The evolution of squamous cell carcinoma (SCC) on sun-exposed areas is a multistep process triggered by ultraviolet radiation (UVR), in which precursor lesions exist. However, the exact classification of the various lesions in this process, mainly solar keratosis (SK), is still disputed, and its pathogenesis requires further clarification.

Objective

To further elucidate the evolution of SCC on sun-damaged skin by correlating the levels of p53 protein expression, a parameter that reflects UVR damage to cells, and the morphology of the lesions that develop on sun-exposed areas.

Methods

Biopsy specimens from normal skin (n = 4), normal skin with various degrees of solar elastosis (SE) (n = 16), various degrees of SK (n = 17) and SCCs from sun-exposed (n = 12) and sun-protected (n = 7) areas were stained with anti-p53 antibodies. A semiquantitative evaluation of the degree of staining was performed and correlated with the histological features.

Results

Nuclear staining in keratinocytes was observed already in normal skin with mild SE and was increased gradually to its highest level of expression in advanced SK. It was also expressed in SCCs, but to a lesser degree. Statistical analysis revealed association between the morphology of the lesion and the level of p53 expression (P < .01); it also showed that in general the level of p53 is correlated with the histology of the lesion (P < .001). Furthermore, with regard to p53 expression, two groups of lesions exist: one showing a low level of expression of p53 that includes normal skin, skin with various degrees of SE and SCC from sun-protected areas, and a second group showing a high level of expression that includes SK and SCC occurring on sun-damaged skin.

Limitation

This is an immunohistochemical study of relatively few cases and in which the antibody detects all types of p53 protein.

Conclusions

This study furnishes further evidence that the development of SCC on sun-damaged skin is a gradual process not only morphologically but also on the molecular level. The process starts already in normal-appearing epidermis with SE. In that respect, SK should be regarded as a part of the continuum in the development of SCC, analogous to the situation in other epithelia. The molecular events involved in the development of SCC on sun-exposed areas may be different from those involving the development of SCC on sun-protected areas.

Le texte complet de cet article est disponible en PDF.

Abbreviations used : BD, SCC, SE, SK, UVR


Plan


 Funding sources: None.
 Conflict of interest: None declared.


© 2007  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 57 - N° 4

P. 669-676 - octobre 2007 Retour au numéro
Article précédent Article précédent
  • Giant verrucous porokeratosis of Mibelli mimicking psoriasis in a patient with psoriasis
  • Clara De Simone, Andrea Paradisi, Guido Massi, Ilaria Proietti, Angela Capponi, Pier Luigi Amerio, Rodolfo Capizzi
| Article suivant Article suivant
  • Treatment of pulsed dye laser–resistant port wine stain birthmarks
  • Zaid F. Jasim, Julian M. Handley

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.